MA
ACOR

MUFG Americas’s Acorda Therapeutics ACOR Stock Holding History

MUFG Americas’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2
Closed -$8K – 1255
2015
Q2 		$8K Hold
2
– – ﹤0.01% 905
2015
Q1 		$8K Hold
2
– – ﹤0.01% 960
2014
Q4 		$10K Hold
2
– – ﹤0.01% 959
2014
Q3 		$8K Hold
2
– – ﹤0.01% 1001
2014
Q2 		$8K Hold
2
– – ﹤0.01% 966
2014
Q1 		$9K Hold
2
– – ﹤0.01% 914
2013
Q4 		$7K Sell
2
-2
-50% -$7.8K ﹤0.01% 954
2013
Q3 		$17K Sell
4
-49
-92% -$211K ﹤0.01% 923
2013
Q2 		$208K Buy
+53
New +$218K ﹤0.01% 880

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MUFG Americas's ACOR Position: Q3 2015 in Review

MUFG Americas sold out of Acorda Therapeutics (ACOR) in Q3 2015, closing a stake of 2 shares — an estimated $8K sold.

MUFG Americas first reported a position in ACOR in Q2 2013 and held it in 9 quarters. The position peaked at $208K in Q2 2013. 176 funds tracked by Wall St. Rank hold ACOR as of Q3 2015.

  • MUFG Americas reported no remaining Acorda Therapeutics position as of Q3 2015 after selling out during the quarter.
  • MUFG Americas sold 2 Acorda Therapeutics shares in Q3 2015, an estimated $8K.
  • MUFG Americas first reported a position in Acorda Therapeutics in Q2 2013 and held it in 9 quarters.
  • MUFG Americas's Acorda Therapeutics position peaked at $208K in Q2 2013.
  • 176 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2015.

Based on MUFG Americas's 13F filing for Q3 2015, filed 10 Nov 2015.